{
    "medicine_id": "d3c9de083e4adb900f287a40ae104de2d7886cf0",
    "platform_id": "12475",
    "metadata": {
        "name": "Abacavir Milpharm 300 mg film coated tablets",
        "composition": "Each film coated tablet contains 300 mg of abacavir as sulfate For the full list of",
        "clinical_particulars": {
            "therapeutic_indications": "Abacavir is indicated in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus HIV infection in adults adolescents and children see sections 4 4 and 5 1 The demonstration of the benefit of abacavir is mainly based on results of studies performed with a twice daily regimen in treatment na\u00efve adult patients on combination therapy see section 5 1 Before initiating treatment with abacavir screening for carriage of the HLAB 5701 allele should be performed in any HIV infected patient irrespective of racial origin see section 4 4 Abacavir should not be used in patients known to carry the HLA B 5701 allele",
            "contraindications": {
                "disease": "Hypersensitivity to abacavir or to any of the excipients listed in section 6 1 See sections 4 4 and 4 8",
                "pregnancy": "Applicable",
                "machine_ops": "Applicable",
                "excipients": ";Cellulose, microcrystalline (Grade \u2013 102);Sodium starch glycolate (Type \u2013 A);Silica colloidal anhydrous;Magnesium stearate;;Hypromellose 2910;Titanium dioxide (E171);Triacetin;Iron oxide yellow (E172);Polysorbate 80",
                "incompatibilities": "Not applicable"
            }
        },
        "revision_date": "2021-11-23"
    }
}